Emily-Rose Martin

Emily-Rose Martin

Auto-generated profile, based on publicly available information

Emily-Rose Martin

University of Exeter Medical School, University of Exeter, Exeter, United Kingdom

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2025 in bioRxiv
Verified
Preprint
Open access
JMJosan G. Martin
Josan G. Martin
EMEmily-Rose Martin
Emily-Rose Martin
NTNatsuki Takamura
Natsuki Takamura
CHCharli E. Harlow
Charli E. Harlow
RBRosemary A. Bamford
Rosemary A. Bamford
AOAsami Oguro-Ando
Asami Oguro-Ando
Growing evidence supports neuroinflammation as a risk factor for neurodevelopmental and psychiatric disorders. Interleukin 6 (IL-6), a classical pro-inflammatory cytokine, has been associated with autism spectrum disorder (ASD)-related phenotypes. To better understand molecular factors that modify neuronal cytokine responses in ASD, we investigated potential roles for JAKMIP1 , a gene linked to chromosome 15q-duplication syndrome (Dup15q; a form of syndromic ASD), in regulating IL-6/STAT3 signaling. We observe that JAKMIP1 deficiency impairs IL-6/STAT3 signaling and IL-6-induced neuritogenesis in SH-SY5Y cells; and discover that JAKMIP1 may regulate STAT3 expression via its C-terminus, which exhibits nucleoplasmic localization. Additionally, we find that IL-6/STAT3 signaling is altered in Dup15q hiPSCs-derived cortical neurons, which display heightened responsiveness to IL-6; though it is unclear whether and how JAKMIP1 contributes to this. Overall, our findings identify JAKMIP1 as a modulator of neuronal IL-6/STAT3 signaling and support that ASD-linked genetic variants can alter the inflammatory landscape of ASD.

22 June 2026 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
EMEmily-Rose Martin
Emily-Rose Martin
JMJosan G. Martin
Josan G. Martin
MRMark A. Russell
Mark A. Russell
AOAsami Oguro-Ando
Asami Oguro-Ando
Autism spectrum disorder (ASD) encompasses a group of neurodevelopmental disorders influenced by genetic and environmental factors, although the molecular mechanisms underlying their interactions remain unclear. We previously reported dysregulated cytokine signalling in chromosome 15q-duplication syndrome (Dup(15q)), a common syndromic form of ASD. Dup(15q) induced pluripotent stem cell (iPSC)-derived neurons exhibit an amplified Signal Transducer and Activator of Transcription-3 (STAT3) response to Interleukin-6 (IL-6), a cytokine often upregulated in ASD. To identify candidate genes within the 15q region that may modify cytokine signalling, we investigated Cytoplasmic FMRP-Interacting Protein 1 (CYFIP1), as CYFIP1 dysregulation has been linked to altered expression of genes involved in immunoregulatory pathways. CYFIP1 was overexpressed using a plasmid vector in human HEK-293 and SH-SY5Y neuroblastoma cells. Following stimulation with IL-6 or Interferon (IFN)-γ, a variety of biochemical assays (qRT-PCR, Western blotting and dual-luciferase reporter assays) and neurite tracing experiments were performed to assess the effects of increased CYFIP1 expression on IL-6/STAT3 and IFN-γ/STAT1 signaling responses. CYFIP1-overexpression HEK-293 cells display reduced STAT3 and STAT1 expression, but enhanced IL-6-induced/IFN-γ-induced STAT3/STAT1 transcriptional activity. Furthermore, CYFIP1-overexpression in SH-SY5Y cells was associated with reduced basal neurite outgrowth and altered IL-6-associated neurite outgrowth. These findings suggest that CYFIP1-overexpression modifies cytokine-responsive transcriptional pathways in vitro and provides novel insight into how CYFIP1 dysregulation may contribute to dysregulated cytokine signaling in ASD, advancing our understanding of the molecular mechanisms underlying neuroinflammatory processes in this disorder.

24 October 2025 in bioRxiv
Verified
Preprint
Open access
EMEmily-Rose Martin
Emily-Rose Martin
JMJosan G. Martin
Josan G. Martin
MRMark A. Russell
Mark A. Russell
AOAsami Oguro-Ando
Asami Oguro-Ando
Autism spectrum disorder (ASD) encompasses a group of neurodevelopmental disorders characterised by impaired social interaction, delayed language development, and repetitive or restrictive behaviours. While both genetic and environmental factors contribute to ASD, the specific molecular mechanisms underlying these interactions remain unclear. In a recent preprint, we showed that cytokine signaling may be dysregulated in chromosome 15q-duplication syndrome (Dup(15q)), one of the most common syndromic forms of ASD. Specifically, Dup(15q) induced pluripotent stem cells (iPSC)-derived neurons exhibit an amplified Signal Transducer and Activator of Transcription-3 (STAT3) response to Interleukin-6 (IL-6), a proinflammatory cytokine often upregulated in ASD. To identify which gene in the 15q region may be responsible for modifying cytokine signalling responses in Dup(15q), we focus on the Cytoplasmic FMRP-Interacting Protein 1 (CYFIP1 ) gene, as increased CYFIP1 dosage in Dup(15q) is associated with increased severity of neurobehavioral symptoms in individuals with Dup(15q) and CYFIP1 dysregulation has been linked to altered expression of various genes involved in immunoregulatory signalling pathways. Here, we explore the eeects of CYFIP1 overexpression ( CYFIP1 -OE) on cytokine signaling, demonstrating that CYFIP1 -OE in HEK293 cells modifies the expression and activity of several cytokine signaling-related transcription factors, including STAT3 and STAT1. Additionally, we use SH-SY5Y neuroblastoma cells to assess neuron-related phenotypes, showing that CYFIP1 -OE alters IL-6-induced neurite outgrowth. These findings provide novel insights into how CYFIP1 may contribute to dysregulated cytokine responses in ASD, advancing our understanding of the molecular mechanisms that underlie neuroinflammatory processes in this disorder.

23 October 2025 in bioRxiv
Verified
Preprint
Open access
EMEmily-Rose Martin
Emily-Rose Martin
JMJosan G. Martin
Josan G. Martin
KLKaiyven A. Leslie
Kaiyven A. Leslie
MRMark A. Russell
Mark A. Russell
AOAsami Oguro-Ando
Asami Oguro-Ando
Background: Investigating the subcellular distribution of proteins is crucial for understanding complex cell behaviours and disease mechanisms. Fluorescence microscopy is a key tool for visualising protein localisation. However, its application is often hindered by the lack of high-quality antibodies, and the common approach to overexpress recombinant fusion constructs tagged with fluorescent proteins can introduce artefacts. Endogenous protein tagging, where the sequence for a tag (typically a peptide or fluorescent protein) is integrated into the native genetic sequence encoding a protein of interest, can be used to overcome these limitations, enabling proteins to be visualised without the need for antibodies against the target protein and avoiding complications associated with recombinant protein overexpression. ORANGE (Open Resource for the Application of Neuronal Genome Editing) is a CRISPR-Cas9-based endogenous protein tagging technique which relies on homology-independent targeted integration (HITI)-mediated gene editing. Utilising HITI as the DNA repair pathway of choice gives ORANGE the advantage of being less error-prone than classical homology-directed repair (HDR)-based endogenous protein tagging techniques and additionally, means it can be used in post-mitotic cells. Results: We applied the ORANGE system to tag three proteins, CYFIP1, JAKMIP1, and STAT3, and confirmed that the expressed fusion proteins demonstrate expected subcellular localisations through fluorescence microscopy. Unexpectedly, the efficiency of ORANGE editing was less than 1% in HEK293 cells, despite high transfection efficiency. To improve the editing efficiency associated with ORANGE, we combined the ORANGE method with an established Sleeping Beauty transposase/CRISPR-Cas9 fusion technique, which has been shown to enhance HITI-mediated gene editing. Using this new method, which we term Sleeping ORANGE, we successfully tagged CYFIP1 with the fluorescent protein mNeonGreen. Importantly, through fluorescence microscopy and flow cytometry, we demonstrate that Sleeping ORANGE increased gene-editing efficiency by approximately 4- to 6-fold compared to the original ORANGE technique. Conclusions: We have developed a method to improve the editing efficiency associated with the ORANGE technique, and with further research to ensure that the fluorescent tags are correctly inserted into their target gene without off-target effects, the Sleeping ORANGE technique may form a valuable tool for researchers to use to better study protein subcellular localisation and dynamics.